Personalized Follow-up Program in the Type 2 Diabetes Prevention

Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · May 28, 2021

Keywords

ClinConnect Summary

This clinical trial is looking to create a personalized follow-up program aimed at preventing type 2 diabetes. Type 2 diabetes is a common condition that affects how your body uses sugar, and it's often linked to lifestyle choices, such as diet and exercise. Many people may not even realize they have it, as the symptoms can be silent for years. The study will focus on people aged 65 to 74 who score 10 or more on a screening tool called FINDRISC, which helps identify those at risk for developing diabetes.

If you decide to participate in this trial, you will join a program designed to help manage and reduce your risk of developing type 2 diabetes. It's important to note that you cannot already have a diagnosis of type 2 diabetes to take part in this study. The trial is not yet recruiting participants, but it represents an exciting step toward a new approach to health care that emphasizes prevention rather than just treating the disease after it occurs.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Person with a FINDRISC score ≥ 10 points
• • Person who has given his/her express written and informed consent
• Exclusion Criteria:
• • - Person already diagnosed with a type 2 diabetes